High Risk and Low Benefit in Pfizer’s Pursuit of Allergan by ROBERT CYRAN

By ROBERT CYRAN

Buying Allergan would give the drug giant a low-tax domicile in Ireland and one good drug, Botox. But Allergan would accrue nearly all of the upside.

Published: November 20, 2015 at 12:00AM

from NYT Business Day http://ift.tt/1OT8eWd

from WordPress http://ift.tt/1MWreB4
via Hadi Aboukhater